2016 annual financial data

Tempest Therapeutics 2016 Financial results

Tempest Therapeutics 2016 financial results with verified reported values.

Direct answer

Revenue was 653,000 USD.

Operating income was -81,012,000 USD and net income was -82,260,000 USD.
Operating cash flow was -61,734,000 USD.

Get free Tempest Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
653,000 USD
Operating income
-81,012,000 USD
Net income
-82,260,000 USD
Operating cash flow
-61,734,000 USD